← Back to all trials
Recruiting
NCT07623668
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Conditions: Optic Neuritis
Sex: All
Ages: 18 Years – 50 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 210
Sponsor: Oculis
Location: Neuro-Eye Clinical Trials Houston Texas
Summary
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON).
Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
Eligibility Criteria
Key Inclusion Criteria:
* Adult men and women (aged 18 to 50 years) with the first episode of ON in the study eye, associated with unilateral visual loss.
* Onset of visual loss symptoms in the previous 12 days before first administration of study treatment.
Key Exclusion Criteria:
\- Have a history or presence of any disorder or condition that may, in the opinion of the Investigator, likely interfere with the interpretation of the study results or participant safety
Source: ClinicalTrials.gov (NCT07623668). StuddyBuddy aggregates publicly available trial information.
